Logo
x

Search category

Subscribe Now

US

The US FDA Launches 5-Year Action Plan for Neurodegenerative Disease

The US FDA Launches 5-Year Action Plan for Neurodegenerative Disease

The US FDA Extends Review Period of Myfembree’s sNDA to Treat Moderate to Severe Pain Associated with Endometriosis

The US FDA Extends Review Period of Myfembree’s sNDA to Treat Moderate to Severe Pain Associated with Endometriosis

The US FDA Issued Complete Response Letter to Hutchmed’s Surufatinib for the Treatment of Advanced Neuroendocrine Tumors

The US FDA Issued Complete Response Letter to Hutchmed’s Surufatinib for the Treatment of Advanced Neuroendocrine Tumors

The US FDA Extends BLA Review for Regeneron’s REGEN-COV for the Treatment and Prophylaxis of COVID-19

The US FDA Extends BLA Review for Regeneron’s REGEN-COV for the Treatment and Prophylaxis of COVID-19

The US FDA Approved First Breathalyzer to Detect COVID-19

The US FDA Approved First Breathalyzer to Detect COVID-19

Nobelpharma’s Hyftor Receives the US FDA’s Approval for the Treatment of Facial Angiofibroma in Patients with TSC

Nobelpharma’s Hyftor Receives the US FDA’s Approval for the Treatment of Facial Angiofibroma in Patients with TSC

Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2022 PharmaShots - All Rights Reserved.